首页> 外文OA文献 >Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization

【2h】

Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization

机译：用于释放优化的改性壳聚糖微粒中氟替卡松丙酸丁酯和Salmeterol XinaFoate的微胶囊

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nina Maria Ainali; Eleftheria Xanthopoulou; Georgia Michailidou; Alexandra Zamboulis; Dimitrios N. Bikiaris;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study [J] . Kai Michael Beeh, Anne-Marie Kirsten, Ana-Maria Tanase, International Journal of Chronic Obstructive Pulmonary Disease . 2018,第1期

机译：与中度至非常重度COPD患者相比，醋酸茚达特罗/糠酸莫美他松与沙美特罗新萘甲酸/丙酸氟替卡松相比，肺功能持续改善：II期随机，双盲12周研究的结果
2. Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device [J] . K.S., J.H., Jin, Pharmaceutical development and technology . 2018,第1a10期

机译：用胶囊基装置配制新型干粉吸入氟酮丙酸盐和萨米非甲酸盐
3. Particle interactions of fluticasone propionate and salmeterol xinafoate detected with single particle aerosol mass spectrometry (SPAMS) [J] . Martin W. Jetzer, Bradley D. Morrical, David P. Fergenson, International Journal of Pharmaceutics . 2017,第1期

机译：用单粒子气溶胶质谱（垃圾邮件）检测氟基丙酸丙酯和Salmeterol Xinafoate的颗粒相互作用（垃圾邮件）
4. Human macrophages release higher IL-1ra over IL-1beta when stimulated by block acetylated chitosan microparticles and not by random acetylated chitosans or water-soluble oligomers [C] . David Fong, Pascal Gregoire-Gelinas, Marc Lavertu, World biomaterials congress . 2016

机译：当被封闭的乙酰化壳聚糖微粒而不是随机乙酰化的壳聚糖或水溶性低聚物刺激时，人类巨噬细胞释放的IL-1ra高于IL-1beta
5. Microencapsulation of chlorpheniramine maleate-resin particles with cross-linked chitosan as a sustained release dosage form. [D] . Huang, Ruo Gu. 1998

机译：以交联壳聚糖作为缓释剂型对氯苯那敏马来酸酯树脂颗粒进行微囊化。
6. Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized double-blind 12-week study [O] . Kai Michael Beeh, Anne-Marie Kirsten, Ana-Maria Tanase, 2018

机译：与中度至非常重度COPD患者相比醋酸茚达特罗/糠酸莫美他松与沙美特罗西那福酯/丙酸氟替卡松相比肺功能持续改善：II期随机双盲12周研究的结果
7. P177 Fluticasone propionate/formoterol fumarate combination therapy is as effective as fluticasone propionate/salmeterol xinafoate in the treatment of asthma: a randomised controlled trial [O] . A. Bodzenta-Lukaszyk, A. Dymek, H. Mansikka 2010

机译：P177氟替卡松丙酸酯/福莫特罗富马酸盐联合疗法如散发物丙酸盐/萨米特蛋白在治疗哮喘：随机对照试验中有效

Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization

著录项

引文网络

相似文献

相关主题

期刊订阅